Status:
UNKNOWN
Parenteral Fish Oil in Major Laparoscopic Abdominal Surgery
Lead Sponsor:
Wei Zhou
Conditions:
Gastric Tumor
Pancreatic Tumor
Eligibility:
All Genders
15-85 years
Phase:
PHASE4
Brief Summary
The aim of this study is to assess the effect of postoperative parenteral fish oil on clinical outcome and immune function after major laparoscopic abdominal surgery.
Detailed Description
Postoperative patients are randomized by a sealed envelope to receive either a 50:50 (vol/vol) mixture of an oil rich in medium-chain fatty acids and soybean oil (termed MCT/LCT) or a mixture of MCT/L...
Eligibility Criteria
Inclusion
- Patients undergoing an elective major laparoscopic abdominal surgery and required at least 5 days of parenteral nutrition
Exclusion
- Metabolic disease
- Chronic kidney or liver failure
- Shock
- Contraindications for lipid administration
- PN during the 15 days before hospitalisation
Key Trial Info
Start Date :
April 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2013
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01819961
Start Date
April 1 2013
End Date
December 1 2013
Last Update
March 28 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sir Run Run Shaw Hosptial
Hangzhou, Zhejiang, China, 310016